Dossier · BILL · Dormant
BILL · BILL Holdings, Inc. · Stock research
Last analysed ·
Current thesis
Self-help re-rate on a 12–13% grower: a 30% headcount cut plus a $1.0B buyback turned BILL GAAP-profitable and carried price from the 2026-06-22 low of $31.96 to $47.99 on 2026-08-07. The date moved — Q4/FY2026 lands 2026-08-19 after the close, a week earlier than assumed, and it is the binary that decides whether the cost cut is recurring leverage or a one-time bank.
Invalidation trigger
A weekly close below $44 erases the entire advance since the 2026-07-17 close of $44.66 and breaks the post-Q3 recovery leg; secondary confirmation if the 2026-08-19 Q4/FY2026 print or the FY2027 guide puts core-revenue growth under ~13%.
Thesis status
Open commitment catalyst in 10dscored if the trigger above fires How this is scored →Latest analysis and events for BILL —
As of 2026-08-09, orbyd's latest analysis for BILL Holdings, Inc. (BILL): Self-help re-rate on a 12–13% grower: a 30% headcount cut plus a $1.0B buyback turned BILL GAAP-profitable and carried price from the 2026-06-22 low of $31.96 to $47.99 on 2026-08-07. The date moved — Q4/FY2026 lands 2026-08-19 after the close, a week earlier than assumed, and it is the binary that decides whether the cost cut is recurring leverage or a one-time bank.
Invalidation trigger: A weekly close below $44 erases the entire advance since the 2026-07-17 close of $44.66 and breaks the post-Q3 recovery leg; secondary confirmation if the 2026-08-19 Q4/FY2026 print or the FY2027 guide puts core-revenue growth under ~13%.
Next dated event on file: — catalyst in 10d.
Current Thesis
The leg on offer is a self-help re-rate, not a growth re-acceleration: a 12–13% top-line business using a workforce cut of up to 30% and a $1.0B repurchase authorization (both announced with Q3 FY2026 on 2026-05-07) to turn a de-rated multiple into GAAP profit and a shrinking share count. Since the last read (2026-07-17 close $44.66) the tape has extended to $47.99 on 2026-08-07, -14.8% from the 52-week high of $56.31, with RSI(14) at 57.7 — the advance has cooled rather than gone vertical. The calendar also moved: on 2026-07-22 BILL fixed fiscal Q4/FY2026 results for Wednesday 2026-08-19, after the close (call 1:30 p.m. PT), one week earlier than the ~08-26 placeholder carried in the prior note. That print is the binary. It carries the first guide built on the post-restructuring cost base and the first full quarter of buyback execution, and nothing between now and then resolves either.
Bullish and bearish views on BILL Holdings, Inc.
The model's bull view on BILL Holdings, Inc. (BILL), in brief: Q3 FY2026 (2026-05-07): first GAAP-profitable quarter in company history — GAAP net income $12.8M, non-GAAP net income $77.2M. The bear view: Growth is maturing. The FY2026 guide of $1,642–1,652M is 12–13% YoY, against 30–70% in prior cycles. TPV was $89B in Q3 FY2026, +12% YoY, across 493,800 businesses — an installed base compounding at roughly the same rate as the payment volume it processes. The re-rate leans on… Both cases follow in full.
Bull Case
- Q3 FY2026 (2026-05-07): first GAAP-profitable quarter in company history — GAAP net income $12.8M, non-GAAP net income $77.2M. Core revenue $371.1M +16% YoY outgrew total revenue $406.6M +13% YoY, so the subscription/transaction mix is compounding faster than the float-sensitive headline.
- $1.0B, 24-month repurchase authorization announced 2026-05-07, inclusive of unused capacity from the August 2025 program. The company disclosed repurchasing ~1.0M shares for ~$52M during Q3 FY2026 — an executing programme, not a paper authorization.
- Workforce reduction of up to 30% with $30–60M of charges (2026-05-07). The market has so far priced this as operating leverage; the move off the 2026-06-22 low of $31.96 to the 2026-08-07 close of $47.99 is what that repricing looks like.
- Sell-side has walked its numbers up rather than down: Truist maintained Hold but raised its target to $44 on 2026-07-24, versus the $38 it cut to on 2026-06-10. JPMorgan carries Overweight at $50. Aggregators also list Goldman Sachs at $50 (from $44) and Oppenheimer at $55 (from $50), though those summaries are undated and should be checked against the primary notes.
- Momentum structure remains constructive: higher lows from the June $31–33 area, a breakout through ~$40, and a July–August grind that has held gains without an RSI extreme.
Bear Case
- Growth is maturing. The FY2026 guide of $1,642–1,652M is 12–13% YoY, against 30–70% in prior cycles. TPV was $89B in Q3 FY2026, +12% YoY, across 493,800 businesses — an installed base compounding at roughly the same rate as the payment volume it processes.
- The re-rate leans on mechanics: cost reduction plus share retirement. A 30% headcount cut is a one-time margin bank, and it puts FY2027 net-new adds and product cadence at risk in a category where Ramp, Brex, Melio and Intuit are all pressing.
- Truist's raised target of $44 (2026-07-24) sits below the 2026-08-07 close of $47.99 — the stock is trading through at least one recently updated Street mark.
- A slice of the profitability comes from interest earned on customer funds held. A Fed easing path pressures that line directly and independently of software execution.
- The 200-day read of $49.42 taken on 2026-07-17 stood as overhead; price at $47.99 on 2026-08-07 is still working under that reference (the moving average itself drifts and needs re-checking).
Setup & Price Structure
- Last completed daily close $47.99 (2026-08-07). 52-week high $56.31, -14.8% away. Three-month return +14.7%. RSI(14) 57.7.
- Reversal base: 2026-06-22 low $31.96 → breakout through ~$40 → $44.66 (2026-07-17) → $47.99 (2026-08-07). The $38–40 zone is the breakout shelf that defines the June-low reversal; $44.66 is the nearer marker, the level from which the current pre-print advance began.
- Narrative life-cycle: MATURING. Dating it: the story is well known and still working (price up from the 2026-06-22 low of $31.96 to $47.99 on 2026-08-07), but it is a margin-and-capital-return story on a 12–13% grower, and the flow is moderating — RSI 57.7 on 2026-08-07 versus the extended condition flagged on 2026-07-17, and sell-side revisions that follow price (Truist $38→$44 on 2026-07-24) rather than lead it. Not ACCELERATING: no new product or demand headline has arrived since 2026-05-07. Not SATURATED: a Hold-rated house at $44 and roughly 42% of the analyst panel at Hold is not a mainstream crowd.
- Crowding/positioning observables, stated as observables: (1) an earnings binary 2026-08-19 after the close, confirmed 2026-07-22 — everything compresses into one date; (2) the $1.0B authorization is a standing bid, but open-market execution customarily pauses in the pre-print blackout, so the mechanical support is thinnest exactly into the event; (3) price trades above at least one recently refreshed Street target ($44, 2026-07-24); (4) price sits under the $49.42 200-day reference of 2026-07-17, so the advance has not yet cleared the level that separates a bounce from a trend change. No insider Form 4 or equity-issuance data was located for the period since 2026-07-17; that absence is not evidence either way.
Catalyst Calendar (next 30 days)
- 2026-08-19 (confirmed 2026-07-22) — Q4 and full-year FY2026 results, after the close, call 1:30 p.m. PT.
- ~2026-08-28 (est.) — FY2026 Form 10-K filing window following the print. Resolves: the audited float-income disclosure and the remaining repurchase capacity, both of which the press release usually summarises but does not fully break out.
What Would Change Our Mind
The structural break is the loss of the leg built since mid-July. A weekly close below $44 erases the entire advance from the 2026-07-17 close of $44.66 and puts price back inside the June-reversal range, at which point the 2026-08-19 print would have functioned as a sell-the-news rather than a confirmation. A deeper failure — a weekly close back under the $38–40 breakout shelf — would end the June-low reversal structure outright.
On fundamentals, the specific datapoint that flips the read is core-revenue growth decelerating under ~13% at the 2026-08-19 print, or an FY2027 guide implying total revenue growth below the 12–13% FY2026 pace. Either would show the cost cut bought margin at the price of the top line. A Q4 repurchase disclosure materially below the ~$52M Q3 pace would say the standing bid is weaker than the authorization implies.
On the other side, an FY2027 guide above 13% with the restructured cost base intact, plus a clean weekly close above the $49.42 area, would move this from a bounce into a trend reclaim.
Correlation Notes
- Read-through cluster: Intuit (SMB back-office and payments demand tone), AvidXchange, and Ramp/Brex/Melio commentary on AP/AR competition. Intuit's fiscal Q4 typically lands in late August; the exact date was not verified here and should be checked before relying on it as a sequencing marker.
- Rate sensitivity is direct rather than thematic: interest on customer funds held is a real revenue line, so the front-end path feeds the P&L independently of software growth.
- The name trades with de-rated mid-cap SaaS on multiple and with SMB payment-volume proxies on fundamentals. TPV of $89B growing +12% (Q3 FY2026) is the cleanest public gauge of the underlying SMB spend cycle in this business.
- Broad-tape risk is generic: the 2026-07-15 memory-chip selloff that dragged the Nasdaq 100 lower is the kind of factor move that hits this name without changing anything inside it.
Notes
- Fiscal year ends June 30. Q4/FY2026 results confirmed for 2026-08-19 after the close, call 1:30 p.m. PT (announced 2026-07-22).
- BILL is B2B SMB financial-operations automation — AP/AR, Divvy spend cards, invoicing. Screens that bucket it with consumer fintech mis-frame the demand driver.
- The $1.0B repurchase authorization runs 24 months from 2026-05-07; open-market execution customarily pauses during the pre-earnings blackout.
- Part of reported profitability is interest income on customer funds held, so the front-end rate path moves the P&L independently of software growth.
- The 200-day reading of $49.42 is dated 2026-07-17 and drifts; re-check the current value before treating it as a live level.
Related · shared themes
HPE
Hewlett Packard Enterprise Company
Five straight up sessions took HPE to a $53.22 close on 2026-08-07 with the 2026-08-04 gap floor at $50.24 still untested; Trefis put the five-day move at +19.8% against +5.6% for the S&P 500, so this leg is no longer pure sector beta. Forward P/E 13.79 versus 49.66 trailing. The still-unconfirmed ~2026-09-02 Q3 print against the $11.5–12.1B / $0.88–0.93 guide is the binary.
OKTA
Okta, Inc.
Identity-security re-rating in its second, sell-side-led leg; the upgrade wave is still building nearly two months post-print — Wells Fargo lifted its target to $150 from $100 on 2026-07-20, collapsing the low-end dispersion. Cyber theme ACCELERATING, this leg maturing; open risk is paying up for a stretched 52-week-high tape.
DAVE
Dave Inc.
Beat-and-raise sold hard: $430.16 on 08-05 to $317.93 on 08-07, -26.1% in two sessions on the window's heaviest volume, while four brokers raised targets to $449–$490 on 08-06. Growth intact (FY26 guide up to $725–735M, adj EPS $17.00–17.50); the multiple broke (forward P/E 17.29 from 26.52). Narrative SATURATED, no dated fundamental gate before the Q3 print.
HNGE
Hinge Health, Inc.
Digital-MSK profitability re-rate broke out in May and was pushed into open price discovery by the 2026-06-09 mid-quarter raise (Q2 to $200–202M, +45%; FY26 to $818–824M). But nine sell-side target hikes in two weeks plus accelerating insider selling mark a late, distribution-prone phase, with no company catalyst until the ~2026-08-04 Q2 print.
See also · stocks to watch